Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients
Public ClinicalTrials.gov record NCT01855880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase IIa, randomised, double-blind, placebo-controlled, multiple dose, multi-center study of AbGn-168H in subjects with moderate to severe chronic plaque psoriasis.The objectives of this study is to investigate efficacy, safety, tolerability, and pharmacokinetics (PK) of multiple doses of AbGn-168H administered intravenously to patients with moderate to severe chronic plaque psoriasis.
Study identification
- NCT ID
- NCT01855880
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2013 (Type not available)
- Primary completion
- Feb 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- May 8, 2015
2013 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baptist Health Certer for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Northwest AR Clinical Trials | Rogers | Arkansas | 72758 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33472 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Progressive Medical Research | Orange | Florida | 32127 | — |
| Olympian Clinical Research | Tampa | Florida | 33609 | — |
| DawesFretzin Clinical Research Group, LLC. | Indianaopoli | Indiana | 46256 | — |
| Indiana University Dermatology | Indianapolis | Indiana | 46202 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| University Urology Associates & Manhattan Research Associates | New York | New York | 10016 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Research Affiliation | Oklahoma City | Oklahoma | 73112 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
| Suzanne Bruce and Associates, The Center for Skin Research | Huston | Texas | 77056 | — |
| West End Dermatology Assotiate | Richmond | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01855880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2015 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01855880 live on ClinicalTrials.gov.